Valproate/Lamotrigine and Growth Retardation
Growth and bone metabolism were evaluated in 27 boys and 26 girls, aged 3 to 17 years (mean 9.2 yrs), with epilepsy treated with valproate (VPA) and/or lamotrigine (LTG) for >2 years, in a study at McMaster University and Children’s Hospital, Hamilton, Ontario, Canada.
Saved in:
| Main Author: | |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Pediatric Neurology Briefs Publishers
2001-12-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/1715 |
| Tags: |
No Tags, Be the first to tag this record!
|